WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 |
Return to index |
|
|
|
|
|
Order |
Gene |
Description |
ref_hepatocyte |
HepG2 |
HepG2.C3A |
HuH.7 |
SNU475 |
THLE |
liver |
1 |
ISG15 |
Ubiquitin-like protein ISG15 |
[1] |
-2.64[2] |
-2.21[3] |
-3.40[4] |
-4.01[5] |
-4.87[6] |
-2.91[7] |
2 |
JUN |
Transcription factor AP-1 |
[8] |
-0.97[9] |
-2.33[10] |
-2.14[11] |
-2.41[12] |
-1.56[13] |
-2.32[14] |
3 |
TNFRSF1A |
Tumor necrosis factor receptor superfamily member 1A |
[15] |
-0.95[16] |
-1.23[17] |
-1.02[18] |
-0.34[19] |
0.12[20] |
-0.44[21] |
4 |
CAV1 |
Caveolin-1 |
[22] |
-7.31[23] |
-9.96[24] |
-3.77[25] |
0.67[26] |
-0.41[27] |
-2.51[28] |
5 |
STAT1 |
Signal transducer and activator of transcription 1-alpha/beta |
[29] |
-0.55[30] |
-1.29[31] |
-0.27[32] |
1.82[33] |
-0.17[34] |
0.43[35] |
6 |
NFKB2 |
Nuclear factor NF-kappa-B p100 subunit |
[36] |
-1.24[37] |
-0.77[38] |
-0.40[39] |
-2.09[40] |
-0.96[41] |
-3.53[42] |
7 |
JAK1 |
Tyrosine-protein kinase JAK1 |
[43] |
0.04[44] |
-0.30[45] |
-0.20[46] |
-0.08[47] |
0.84[48] |
1.01[49] |
8 |
RXRA |
Retinoic acid receptor RXR-alpha |
[50] |
-0.53[51] |
-0.56[52] |
0.21[53] |
-0.70[54] |
-0.75[55] |
1.63[56] |
9 |
NRAS |
GTPase NRas |
[57] |
0.15[58] |
0.76[59] |
1.09[60] |
0.29[61] |
0.14[62] |
-0.77[63] |
10 |
HRAS |
GTPase HRas |
[64] |
-1.48[65] |
-2.01[66] |
-2.89[67] |
-1.66[68] |
-1.59[69] |
-3.18[70] |
11 |
ETS1 |
Protein C-ets-1 |
[71] |
-3.28[72] |
-12.45[73] |
-9.73[74] |
-0.80[75] |
0.33[76] |
-0.60[77] |
12 |
MAPK1 |
Mitogen-activated protein kinase 1 |
[78] |
1.23[79] |
1.55[80] |
1.29[81] |
1.14[82] |
1.07[83] |
1.26[84] |
13 |
CCL2 |
C-C motif chemokine 2 |
[85] |
-13.87[86] |
[87] |
-13.20[88] |
-4.83[89] |
-2.38[90] |
-4.21[91] |
14 |
KRAS |
GTPase KRas |
[92] |
-0.99[93] |
-0.84[94] |
0.68[95] |
0.09[96] |
0.03[97] |
0.16[98] |
15 |
MAPK14 |
Mitogen-activated protein kinase 14 |
[99] |
1.00[100] |
1.24[101] |
0.74[102] |
0.97[103] |
0.73[104] |
0.77[105] |
16 |
PRKCZ |
Protein kinase C zeta type |
[106] |
-0.01[107] |
0.55[108] |
-1.53[109] |
-3.01[110] |
-4.93[111] |
-2.16[112] |
17 |
MAPK8 |
Mitogen-activated protein kinase 8 |
[113] |
-1.92[114] |
-0.34[115] |
-1.55[116] |
-1.61[117] |
-1.47[118] |
-1.03[119] |
18 |
NFKB1 |
Nuclear factor NF-kappa-B p105 subunit |
[120] |
0.19[121] |
0.05[122] |
-0.25[123] |
-0.96[124] |
0.23[125] |
-0.06[126] |
19 |
CAMK2D |
Calcium/calmodulin-dependent protein kinase type II subunit delta |
[127] |
-0.35[128] |
0.14[129] |
1.58[130] |
-0.03[131] |
-0.56[132] |
0.89[133] |
20 |
STAT2 |
Signal transducer and activator of transcription 2 |
[134] |
-0.45[135] |
1.09[136] |
0.17[137] |
0.82[138] |
0.56[139] |
2.51[140] |
21 |
MAPK13 |
Mitogen-activated protein kinase 13 |
[141] |
1.86[142] |
2.44[143] |
-0.32[144] |
-2.59[145] |
-0.80[146] |
-2.23[147] |
22 |
RXRB |
Retinoic acid receptor RXR-beta |
[148] |
0.54[149] |
1.04[150] |
-0.12[151] |
0.87[152] |
0.03[153] |
-0.40[154] |
23 |
CD40 |
Tumor necrosis factor receptor superfamily member 5 |
[155] |
-1.28[156] |
-2.30[157] |
-10.63[158] |
-3.53[159] |
-1.92[160] |
-1.45[161] |
24 |
TYK2 |
Non-receptor tyrosine-protein kinase TYK2 |
[162] |
0.66[163] |
1.19[164] |
1.24[165] |
0.04[166] |
1.24[167] |
1.47[168] |
25 |
SP3 |
Transcription factor Sp3 |
[169] |
0.95[170] |
2.47[171] |
2.35[172] |
1.44[173] |
1.50[174] |
1.56[175] |
26 |
MAPK9 |
Mitogen-activated protein kinase 9 |
[176] |
0.75[177] |
1.15[178] |
1.13[179] |
1.01[180] |
0.74[181] |
-0.01[182] |
27 |
MAPK3 |
Mitogen-activated protein kinase 3 |
[183] |
1.37[184] |
1.59[185] |
1.55[186] |
-0.29[187] |
0.02[188] |
-1.56[189] |
28 |
RELB |
Transcription factor RelB |
[190] |
-0.76[191] |
-1.01[192] |
-0.84[193] |
-1.72[194] |
-0.22[195] |
-3.02[196] |
29 |
MED1 |
Mediator of RNA polymerase II transcription subunit 1 |
[197] |
2.07[198] |
1.57[199] |
2.39[200] |
1.49[201] |
1.93[202] |
0.76[203] |
30 |
PRKCD |
Protein kinase C delta type |
[204] |
0.62[205] |
1.05[206] |
0.44[207] |
-1.21[208] |
0.22[209] |
-1.58[210] |
31 |
SP1 |
Transcription factor Sp1 |
[211] |
1.34[212] |
1.76[213] |
2.74[214] |
1.96[215] |
1.93[216] |
1.64[217] |
32 |
IKBKB |
Inhibitor of nuclear factor kappa-B kinase subunit beta |
[218] |
0.04[219] |
0.28[220] |
0.30[221] |
-0.45[222] |
-0.08[223] |
0.67[224] |
33 |
CAMK2G |
Calcium/calmodulin-dependent protein
kinase type II subunit gamma |
0.30[225] |
1.69[226] |
1.22[227] |
0.98[228] |
0.82[229] |
0.44[230] |
34 |
PRKCA |
Protein kinase C alpha type |
[231] |
2.36[232] |
2.58[233] |
2.85[234] |
1.44[235] |
2.08[236] |
1.40[237] |
35 |
OAS2 |
2'-5'-oligoadenylate synthase 2 |
[238] |
-2.62[239] |
-6.57[240] |
-10.89[241] |
-1.82[242] |
-1.95[243] |
0.66[244] |
36 |
PLCD1 |
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 |
[245] |
-0.47[246] |
0.59[247] |
0.54[248] |
-1.79[249] |
-0.83[250] |
0.20[251] |
37 |
PLCB3 |
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 |
[252] |
1.53[253] |
1.19[254] |
1.57[255] |
2.00[256] |
1.93[257] |
0.21[258] |
38 |
TLR2 |
Toll-like receptor 2 |
[259] |
-4.02[260] |
-2.43[261] |
-9.51[262] |
-5.68[263] |
1.36[264] |
0.73[265] |
39 |
IL6 |
Interleukin-6 |
[266] |
-8.92[267] |
[268] |
-5.22[269] |
-1.56[270] |
1.23[271] |
[272] |
40 |
MAPK7 |
Mitogen-activated protein kinase 7 |
[273] |
0.96[274] |
0.43[275] |
0.35[276] |
1.10[277] |
1.47[278] |
-0.18[279] |
41 |
PLCB1 |
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 |
[280] |
2.31[281] |
4.12[282] |
3.46[283] |
0.07[284] |
0.84[285] |
1.98[286] |
42 |
IFI27L2 |
Interferon alpha-inducible protein 27-like protein 2 |
[287] |
-0.04[288] |
-0.83[289] |
-3.68[290] |
2.12[291] |
1.91[292] |
-1.40[293] |
43 |
PLCG2 |
1-phosphatidylinositol
4,5-bisphosphate phosphodiesterase gamma-2 |
-1.76[294] |
-7.33[295] |
0.04[296] |
-3.44[297] |
-2.01[298] |
2.20[299] |
44 |
MAPK12 |
Mitogen-activated protein kinase 12 |
[300] |
2.34[301] |
2.18[302] |
3.21[303] |
0.78[304] |
2.31[305] |
-1.42[306] |
45 |
PRKCE |
Protein kinase C epsilon type |
[307] |
0.17[308] |
-1.17[309] |
1.24[310] |
0.27[311] |
0.92[312] |
3.05[313] |
46 |
CAMK2B |
Calcium/calmodulin-dependent protein kinase type II subunit beta |
[314] |
-3.01[315] |
-4.16[316] |
-7.20[317] |
-3.57[318] |
-2.65[319] |
0.63[320] |
47 |
RSAD2 |
Radical S-adenosyl methionine domain-containing protein 2 |
[321] |
-3.33[322] |
-4.74[323] |
-4.70[324] |
-5.26[325] |
-3.93[326] |
0.67[327] |
48 |
NOD2 |
Nucleotide-binding oligomerization domain-containing protein 2 |
[328] |
-2.38[329] |
-4.17[330] |
[331] |
-4.32[332] |
-0.49[333] |
-1.05[334] |
49 |
PRKCH |
Protein kinase C eta type |
[335] |
-0.84[336] |
-4.47[337] |
-2.91[338] |
1.57[339] |
3.48[340] |
2.59[341] |
50 |
TLR4 |
Toll-like receptor 4 |
[342] |
-0.21[343] |
-5.18[344] |
-6.15[345] |
-5.81[346] |
4.89[347] |
3.95[348] |
51 |
PLCB2 |
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 |
[349] |
-2.10[350] |
-6.70[351] |
-8.63[352] |
-2.64[353] |
-3.08[354] |
1.72[355] |
52 |
MAPK11 |
Mitogen-activated protein kinase 11 |
[356] |
-0.65[357] |
-0.58[358] |
-1.55[359] |
-0.35[360] |
1.92[361] |
-0.35[362] |
53 |
CYP24A1 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial |
[363] |
7.67[364] |
2.98[365] |
-2.75[366] |
3.40[367] |
-3.13[368] |
-7.61[369] |
54 |
VDR |
Vitamin D3 receptor |
[370] |
-0.64[371] |
-0.04[372] |
0.52[373] |
1.63[374] |
3.24[375] |
-0.04[376] |
55 |
PRKCB |
Protein kinase C beta type |
[377] |
-7.29[378] |
-5.92[379] |
[380] |
1.77[381] |
-3.25[382] |
3.02[383] |
56 |
IFI44L |
Interferon-induced protein 44-like |
[384] |
-4.70[385] |
[386] |
-6.14[387] |
4.05[388] |
1.97[389] |
3.44[390] |
57 |
IFNG |
Interferon gamma |
[391] |
[392] |
[393] |
[394] |
-1.40[395] |
[396] |
-2.81[397] |
58 |
TNF |
Tumor necrosis factor |
[398] |
0.62[399] |
-1.34[400] |
-6.02[401] |
-2.93[402] |
-5.87[403] |
-2.41[404] |
59 |
PLCE1 |
1-phosphatidylinositol
4,5-bisphosphate phosphodiesterase epsilon-1 |
-1.10[405] |
-1.90[406] |
5.43[407] |
5.31[408] |
1.92[409] |
2.42[410] |
60 |
CD40LG |
CD40 ligand |
[411] |
-5.25[412] |
[413] |
-6.81[414] |
-4.95[415] |
[416] |
-1.10[417] |
61 |
TLR8 |
Toll-like receptor 8 |
[418] |
[419] |
[420] |
[421] |
[422] |
-6.45[423] |
3.14[424] |
62 |
CAMP |
Cathelicidin antimicrobial peptide |
[425] |
-6.38[426] |
[427] |
-6.48[428] |
[429] |
-2.88[430] |
-0.37[431] |
63 |
PRKCQ |
Protein kinase C theta type |
[432] |
0.43[433] |
-2.96[434] |
[435] |
1.42[436] |
3.20[437] |
1.57[438] |
64 |
CYP27B1 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial |
[439] |
2.20[440] |
3.81[441] |
3.12[442] |
0.48[443] |
1.50[444] |
1.15[445] |
65 |
PRKCG |
Protein kinase C gamma type |
[446] |
-1.30[447] |
-0.45[448] |
-2.91[449] |
-1.77[450] |
-1.58[451] |
[452] |
66 |
RXRG |
Retinoic acid receptor RXR-gamma |
[453] |
-4.21[454] |
[455] |
[456] |
-2.77[457] |
[458] |
1.99[459] |
67 |
PLCB4 |
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 |
[460] |
-0.22[461] |
-0.20[462] |
0.72[463] |
8.92[464] |
6.92[465] |
3.28[466] |
68 |
IFNA2 |
Interferon alpha-2 |
[467] |
[468] |
[469] |
[470] |
[471] |
[472] |
[473] |
69 |
DEFB4A |
Beta-defensin 4A |
[474] |
[475] |
[476] |
[477] |
[478] |
[479] |
[480] |
70 |
CXCL8 |
Interleukin-8 |
[481] |
[482] |
[483] |
[484] |
[485] |
[486] |
[487] |
71 |
CAMK2A |
Calcium/calmodulin-dependent protein kinase type II subunit alpha |
[488] |
[489] |
[490] |
[491] |
[492] |
[493] |
[494] |
|
|
|
|
|
|
|
|
|
|